According to Cognitive Market Research, the global dupuytren contracture drug market size was USD 49516.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 23.00% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 19806.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.2% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 14854.95 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 11388.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 25.0% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 2475.83 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.4% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 990.33 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.7% from 2024 to 2031.
The hospital held the highest dupuytren contracture drug market revenue share in 2024.
